PMC:1064895 / 4981-5325 JSONTXT 24 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4336 0-8 IN denotes Although
T4337 9-12 DT denotes the
T4338 13-25 NN denotes contribution
T4339 26-28 IN denotes of
T4340 29-34 NNP denotes IL-17
T4341 35-37 IN denotes in
T4342 38-43 JJ denotes joint
T4343 44-56 NN denotes inflammation
T4344 57-59 IN denotes in
T4345 60-62 NNP denotes RA
T4346 63-66 VBZ denotes has
T4347 67-71 VBN denotes been
T4348 72-82 VBN denotes documented
T4349 83-85 IN denotes in
T4350 86-93 JJR denotes earlier
T4351 94-101 NNS denotes studies
T4352 102-103 NNP denotes [
T4353 103-111 CD denotes 12,15,16
T4354 111-112 NNP denotes ]
T4355 112-113 , denotes ,
T4356 114-117 DT denotes the
T4357 118-131 JJ denotes intracellular
T4358 132-138 NN denotes signal
T4359 139-151 NN denotes transduction
T4360 152-159 NN denotes pathway
T4361 160-163 IN denotes for
T4362 164-169 JJ denotes IL-17
T4363 170-180 NN denotes production
T4364 181-188 VBZ denotes remains
T4365 189-198 JJ denotes uncertain
T4366 198-199 . denotes .
T4367 200-202 IN denotes In
T4368 203-206 DT denotes the
T4369 207-214 JJ denotes present
T4370 215-220 NN denotes study
T4371 221-223 PRP denotes we
T4372 224-228 VBD denotes used
T4373 229-236 JJ denotes various
T4374 237-244 NNS denotes stimuli
T4375 245-247 TO denotes to
T4376 248-259 VB denotes investigate
T4377 260-265 JJ denotes IL-17
T4378 266-276 NN denotes production
T4379 277-279 IN denotes in
T4380 280-284 NNP denotes PBMC
T4381 285-287 IN denotes of
T4382 288-296 NNS denotes patients
T4383 297-301 IN denotes with
T4384 302-304 NNP denotes RA
T4385 305-308 CC denotes and
T4386 309-312 PRP$ denotes its
T4387 313-322 VBG denotes signaling
T4388 323-335 NN denotes transduction
T4389 336-343 NN denotes pathway
T4390 343-344 . denotes .
R2254 T4336 T4348 mark Although,documented
R2256 T4337 T4338 det the,contribution
R2257 T4338 T4348 nsubjpass contribution,documented
R2259 T4339 T4338 prep of,contribution
R2260 T4340 T4339 pobj IL-17,of
R2261 T4341 T4338 prep in,contribution
R2263 T4342 T4343 amod joint,inflammation
R2264 T4343 T4341 pobj inflammation,in
R2266 T4344 T4343 prep in,inflammation
R2267 T4345 T4344 pobj RA,in
R2268 T4346 T4348 aux has,documented
R2270 T4347 T4348 auxpass been,documented
R2271 T4348 T4364 advcl documented,remains
R2272 T4349 T4348 prep in,documented
R2274 T4350 T4351 amod earlier,studies
R2275 T4351 T4349 pobj studies,in
R2276 T4352 T4354 compound [,]
R2278 T4353 T4354 compound "12,15,16",]
R2279 T4354 T4364 nsubj ],remains
R2280 T4355 T4354 punct ",",]
R2281 T4356 T4360 det the,pathway
R2282 T4357 T4360 amod intracellular,pathway
R2283 T4358 T4360 nmod signal,pathway
R2285 T4359 T4360 compound transduction,pathway
R2286 T4360 T4354 appos pathway,]
R2288 T4361 T4360 prep for,pathway
R2290 T4362 T4363 amod IL-17,production
R2291 T4363 T4361 pobj production,for
R2293 T4364 T4364 ROOT remains,remains
R2294 T4365 T4364 acomp uncertain,remains
R2295 T4366 T4364 punct .,remains
R2297 T4367 T4367 ROOT In,In
R2298 T4368 T4370 det the,study
R2299 T4369 T4370 amod present,study
R2301 T4370 T4367 pobj study,In
R2303 T4371 T4372 nsubj we,used
R2304 T4372 T4370 relcl used,study
R2305 T4373 T4374 amod various,stimuli
R2307 T4374 T4372 dobj stimuli,used
R2308 T4375 T4376 aux to,investigate
R2309 T4376 T4372 xcomp investigate,used
R2310 T4377 T4378 amod IL-17,production
R2312 T4378 T4376 dobj production,investigate
R2313 T4379 T4378 prep in,production
R2315 T4380 T4379 pobj PBMC,in
R2316 T4381 T4380 prep of,PBMC
R2317 T4382 T4381 pobj patients,of
R2319 T4383 T4382 prep with,patients
R2320 T4384 T4383 pobj RA,with
R2321 T4385 T4384 cc and,RA
R2323 T4386 T4389 poss its,pathway
R2324 T4387 T4389 amod signaling,pathway
R2326 T4388 T4389 compound transduction,pathway
R2327 T4389 T4384 conj pathway,RA
R2328 T4390 T4367 punct .,In